- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GKOS
Recent news which mentions GKOS
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
September 07, 2022
From Benzinga
Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday
September 07, 2022
From Benzinga
Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate
September 07, 2022
Tickers
GKOS
From Benzinga
Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment
August 24, 2022
Tickers
GKOS
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 03, 2022
From Benzinga
Glaukos Receives FDA 510(k) Clearance For iStent infinite
August 03, 2022
Tickers
GKOS
From Benzinga
The 6 Most Aggressive Growth Stocks to Buy in July
July 12, 2022
From InvestorPlace
From Benzinga
Sight Sciences' Q4 Earnings, FY22 Guidance Beat Street View
March 25, 2022
From Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
February 03, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 12, 2022
From Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
January 12, 2022
From Benzinga
Glaukos' iDose TR Shows Sustained Reduction In Ocular Pressure, Favorable Safety Profile
January 12, 2022
Tickers
GKOS
From Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
January 07, 2022
From Benzinga
From Benzinga
5 Stocks To Watch For January 7, 2022
January 07, 2022
From Benzinga
Glaukos Corp (GKOS) FY 2021 Earnings Call Transcript
November 30, 2021
Tickers
GKOS
From Motley Fool
FDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure
November 11, 2021
From Benzinga
Glaukos Corp (GKOS) Q3 2021 Earnings Call Transcript
November 07, 2021
Tickers
GKOS
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
86 Biggest Movers From Yesterday
November 04, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.